London, United Kingdom

Pantelis Georgiou

This inventor holds 9 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 6 EPO patents. Top assignees: Imperial College Innovations Limited, Dnae Group Holdings Limited, Gene Onyx Limited. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pantelis Georgiou. Retrieved from https://idiyas.com/inventor/pantelis-georgiou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7


 

Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 34(Granted Patents)


Location History:

  • Middlesex, GB (2016)
  • Wembley Middlesex, GB (2017)
  • London, GB (2018 - 2024)

Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Pantelis Georgiou: Innovator in Diabetes Management

Introduction

Pantelis Georgiou, a notable inventor based in London, GB, has made significant contributions to the field of diabetes management through his innovative inventions. With a total of seven patents to his name, Georgiou is at the forefront of developing technologies aimed at improving the lives of individuals with diabetes.

Latest Patents

Georgiou's latest innovations include an "Artificial Pancreas with Neural Signal Input." This groundbreaking apparatus controls the delivery of insulin to a subject by utilizing neural information indicative of food and drink intake, along with signals reflecting the subject's blood glucose levels. The technology features processors that analyze the received data to determine the necessary insulin delivery, showcasing a sophisticated approach to glycemic control.

Another of his significant inventions is the "Automatic Closed-Loop Glucose Control with an Adaptive Meal Bolus Calculator." This method enhances insulin delivery systems by adaptively determining compensation factors based on continuous glucose level readings and anticipated carbohydrate intake. By factoring in these elements, the system aims to optimize insulin meal boluses, further elevating the standard of care in diabetes management.

Career Highlights

Throughout his career, Pantelis Georgiou has collaborated with companies such as Dnae Group Holdings Limited and Imperial College Innovations Limited. His work has provided innovative solutions that harness technology to refine diabetes treatment and improve patient outcomes.

Collaborations

Georgiou has worked alongside distinguished colleagues like Christofer Toumazou and Yan Liu, collaborating in research and development endeavors that aim to push the boundaries of current medical technologies. These partnerships have been crucial in bringing his innovative concepts to fruition, merging expertise to create impactful solutions for diabetes care.

Conclusion

Pantelis Georgiou stands out as a prominent inventor whose groundbreaking patents in diabetes management exemplify how technological advancements can significantly improve healthcare. Through his continuous commitment to innovation, he is setting new standards in the treatment and management of diabetes, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…